Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-27

FDA Approved: ZAFIRLUKAST — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original ANDA for Zafirlukast from Aurobindo Pharma Limited, providing a generic option for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zafirlukast (zafirlukast)

Snippet

ORIG AP for ZAFIRLUKAST (ZAFIRLUKAST)